Much of the focus during the ongoing novel coronavirus pandemic has been on diagnosing and treating the COVID-19 disease, but health officials are also growing increasingly concerned about the psychological toll it’s having on society. As a direct response, US regulators have published a an immediately-in-effect guidance document that relaxes regulations to allow patients to have more access to digital mental-health products.
The US Food and Drug Administration on 15 April published “Enforcement Policy for Digital Health Devices For Treating Psychiatric Disorders During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency.”...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?